Axonics
Irvine, United States · Founded 2012
About Axonics
Axonics develops the Axonics Sacral Neuromodulation System, an implantable device treating overactive bladder, bowel incontinence, and urinary retention. Notably, their long-lasting therapy boasts 93% patient response after 2 years and high satisfaction rates. Recently acquired by Boston Scientific for an undisclosed amount, Axonics previously secured $300M in funding and holds a specialized position in the sacral neuromodulation market. The company focuses on providing a discreet and clinically proven alternative to traditional therapies.
Sectors
Key Products
Axonics Sacral Neuromodulation System
Quick Links
Company Details
- Country
- United States
- City
- Irvine
- Founded
- 2012
- Type
- commercial
Disclaimer: This page is for informational purposes only and should not be considered financial advice. Always conduct your own research and consult with a financial advisor before making investment decisions.